• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急性心肌梗死患者经皮冠状动脉介入治疗期间预测心室颤动的列线图的开发与验证

Development and Validation of a Nomogram to Predict Ventricular Fibrillation During Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction.

作者信息

Liu Ruifeng, Gao Xiangyu, Fan Jihong, Zhao Huiqiang

机构信息

Department of Cardiology, Beijing Friendship Hospital Affiliated to Capital Medical University, 100050 Beijing, China.

出版信息

Rev Cardiovasc Med. 2025 Jul 22;26(7):37301. doi: 10.31083/RCM37301. eCollection 2025 Jul.

DOI:10.31083/RCM37301
PMID:40776936
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12326412/
Abstract

BACKGROUND

Ventricular fibrillation (VF) is a life-threatening complication of acute myocardial infarction (AMI), particularly in patients undergoing percutaneous coronary intervention (PCI). Early identification of high-risk patients is crucial for implementing preventive measures and improving outcomes.

METHODS

This retrospective study analyzed clinical, laboratory, and angiographic data from 155 AMI patients to identify predictors of VF during PCI. Variable selection was performed using least absolute shrinkage and selection operator (LASSO) regression, elastic net regression, and random forest. Independent predictors were identified through multivariable logistic regression, and a nomogram was developed and validated to predict VF risk. Model performance was assessed using receiver operating characteristic (ROC) and calibration curves.

RESULTS

Independent predictors of VF included diabetes (OR = 3.676 (1.365-10.668); = 0.012), neutrophil-to-lymphocyte ratio (NLR) (odds ratio (OR) = 1.149 (1.053-1.265); = 0.002), right coronary artery (RCA) intervention (OR = 3.185 (1.088-9.804); = 0.037), Gensini score (OR = 1.020 (1.007-1.033); = 0.003), and absence of beta blockers (OR = 0.168 (0.054-0.472); = 0.001). The nomogram, incorporating these predictors, demonstrated a strong discriminative ability with an area under the ROC curve (AUC) of 0.882 (0.825-0.939) and good calibration (Hosmer-Lemeshow test, = 0.769). The calibration curve showed a strong alignment between predicted probabilities and observed outcomes, with a mean absolute error of 0.033.

CONCLUSIONS

This study identified diabetes, NLR, RCA intervention, Gensini score, and absence of beta-blocker use as key predictors of VF during PCI in AMI patients. A nomogram incorporating these factors showed strong predictive performance, aiding clinicians in identifying high-risk patients for targeted preventive strategies.

摘要

背景

心室颤动(VF)是急性心肌梗死(AMI)的一种危及生命的并发症,尤其是在接受经皮冠状动脉介入治疗(PCI)的患者中。早期识别高危患者对于实施预防措施和改善预后至关重要。

方法

这项回顾性研究分析了155例AMI患者的临床、实验室和血管造影数据,以确定PCI期间VF的预测因素。使用最小绝对收缩和选择算子(LASSO)回归、弹性网回归和随机森林进行变量选择。通过多变量逻辑回归确定独立预测因素,并开发和验证了一个列线图以预测VF风险。使用受试者工作特征(ROC)曲线和校准曲线评估模型性能。

结果

VF的独立预测因素包括糖尿病(OR = 3.676(1.365 - 10.668);P = 0.012)、中性粒细胞与淋巴细胞比值(NLR)(比值比(OR) = 1.149(1.053 - 1.265);P = 0.002)、右冠状动脉(RCA)介入(OR = 3.185(1.088 - 9.804);P = 0.037)、Gensini评分(OR = 1.020(1.007 - 1.033);P = 0.003)以及未使用β受体阻滞剂(OR = 0.168(0.054 - 0.472);P = 0.001)。纳入这些预测因素的列线图显示出较强的判别能力,ROC曲线下面积(AUC)为0.882(0.825 - 0.939),校准良好(Hosmer-Lemeshow检验,P = 0.769)。校准曲线显示预测概率与观察结果之间高度一致,平均绝对误差为0.033。

结论

本研究确定糖尿病、NLR、RCA介入、Gensini评分以及未使用β受体阻滞剂是AMI患者PCI期间VF的关键预测因素。纳入这些因素的列线图显示出强大的预测性能,有助于临床医生识别高危患者以制定针对性的预防策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38c7/12326412/bc79b94dded2/2153-8174-26-7-37301-g5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38c7/12326412/b9a47ccd9bb4/2153-8174-26-7-37301-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38c7/12326412/e1da64c7cae1/2153-8174-26-7-37301-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38c7/12326412/718950c1517a/2153-8174-26-7-37301-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38c7/12326412/fff8914ceaad/2153-8174-26-7-37301-g4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38c7/12326412/bc79b94dded2/2153-8174-26-7-37301-g5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38c7/12326412/b9a47ccd9bb4/2153-8174-26-7-37301-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38c7/12326412/e1da64c7cae1/2153-8174-26-7-37301-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38c7/12326412/718950c1517a/2153-8174-26-7-37301-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38c7/12326412/fff8914ceaad/2153-8174-26-7-37301-g4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38c7/12326412/bc79b94dded2/2153-8174-26-7-37301-g5.jpg

相似文献

1
Development and Validation of a Nomogram to Predict Ventricular Fibrillation During Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction.急性心肌梗死患者经皮冠状动脉介入治疗期间预测心室颤动的列线图的开发与验证
Rev Cardiovasc Med. 2025 Jul 22;26(7):37301. doi: 10.31083/RCM37301. eCollection 2025 Jul.
2
A predictive nomogram for intramyocardial hemorrhage in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention based on coronary angiography-derived index of microcirculatory resistance.基于冠状动脉造影衍生的微循环阻力指数的ST段抬高型心肌梗死患者行直接经皮冠状动脉介入治疗时心肌内出血的预测列线图。
BMC Cardiovasc Disord. 2025 Aug 7;25(1):584. doi: 10.1186/s12872-025-05057-0.
3
Development and validation of a nomogram model for predicting the occurrence of necrotizing enterocolitis in premature infants with late-onset sepsis.预测晚发性败血症早产儿坏死性小肠结肠炎发生的列线图模型的开发与验证
Eur J Med Res. 2025 Jul 8;30(1):595. doi: 10.1186/s40001-025-02857-0.
4
Clinical diagnostic and prognostic value of homocysteine combined with hemoglobin [f (Hcy-Hb)] in cardio-renal syndrome caused by primary acute myocardial infarction.同型半胱氨酸联合血红蛋白[f(Hcy-Hb)]在原发性急性心肌梗死所致心肾综合征中的临床诊断及预后价值
J Transl Med. 2025 Jul 23;23(1):813. doi: 10.1186/s12967-025-06512-4.
5
Development and validation of an LDH-focused nomogram for the early prediction of heart failure in patients with acute ST-elevation myocardial infarction after percutaneous coronary intervention.用于经皮冠状动脉介入治疗后急性ST段抬高型心肌梗死患者心力衰竭早期预测的以乳酸脱氢酶为重点的列线图的开发与验证
Lipids Health Dis. 2025 Jul 9;24(1):233. doi: 10.1186/s12944-025-02649-9.
6
Prediction of Percutaneous Coronary Intervention Success in Patients With Moderate to Severe Coronary Artery Calcification Using Machine Learning Based on Coronary Angiography: Prospective Cohort Study.基于冠状动脉造影的机器学习预测中重度冠状动脉钙化患者经皮冠状动脉介入治疗的成功率:前瞻性队列研究
J Med Internet Res. 2025 Jul 11;27:e70943. doi: 10.2196/70943.
7
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
8
A predictive model for heart failure with preserved ejection fraction following acute myocardial infarction: the HFpEF-AMI score.急性心肌梗死后射血分数保留的心力衰竭预测模型:HFpEF-AMI评分
BMC Cardiovasc Disord. 2025 Jul 23;25(1):535. doi: 10.1186/s12872-025-04969-1.
9
An individualized nomogram for predicting risk of sepsis in patients with pyogenic liver abscesses: a 10 years retrospective analysis.预测化脓性肝脓肿患者脓毒症风险的个体化列线图:一项10年回顾性分析
Front Med (Lausanne). 2025 Jul 9;12:1555656. doi: 10.3389/fmed.2025.1555656. eCollection 2025.
10
A New Model for the Prediction of Intramyocardial Hemorrhage in ST-Segment Elevation Myocardial Infarction Patients After Emergency Percutaneous Coronary Intervention.一种预测ST段抬高型心肌梗死患者急诊经皮冠状动脉介入治疗后心肌内出血的新模型
Catheter Cardiovasc Interv. 2025 Sep;106(3):1966-1978. doi: 10.1002/ccd.70042. Epub 2025 Jul 23.

本文引用的文献

1
Development and Validation of a Nomogram Model for Predicting in-Hospital Mortality in non-Diabetic Patients with non-ST-Segment Elevation Acute Myocardial Infarction.非糖尿病合并非 ST 段抬高型急性心肌梗死患者住院死亡率预测列线图模型的建立与验证
Clin Appl Thromb Hemost. 2024 Jan-Dec;30:10760296241276524. doi: 10.1177/10760296241276524.
2
[Impact of obesity and diabetes on health and cardiovascular disease].[肥胖与糖尿病对健康及心血管疾病的影响]
Aten Primaria. 2024 Dec;56(12):103045. doi: 10.1016/j.aprim.2024.103045. Epub 2024 Jul 14.
3
Risk factors for ventricular arrhythmias after emergency percutaneous coronary intervention in elderly patients with acute myocardial infarction.
老年急性心肌梗死患者急诊经皮冠状动脉介入治疗后室性心律失常的危险因素
Am J Transl Res. 2024 May 15;16(5):1678-1689. doi: 10.62347/WZNF8280. eCollection 2024.
4
Percutaneous coronary intervention for ventricular fibrillation in the setting of an anomalous right coronary artery.异常右冠状动脉情况下经皮冠状动脉介入治疗室颤
Clin Case Rep. 2023 Nov 2;11(11):e8052. doi: 10.1002/ccr3.8052. eCollection 2023 Nov.
5
Expression and clinical significance of NRLP1 in patients with ST-segment elevation myocardial infarction combined with malignant ventricular arrhythmia.NRLP1在ST段抬高型心肌梗死合并恶性室性心律失常患者中的表达及临床意义
Pak J Med Sci. 2023 Jul-Aug;39(4):972-977. doi: 10.12669/pjms.39.4.7324.
6
A combined index constructed based on NLR and PLR is associated with in-hospital mortality risk in patients with acute myocardial infarction.基于中性粒细胞与淋巴细胞比值(NLR)和血小板与淋巴细胞比值(PLR)构建的联合指数与急性心肌梗死患者的院内死亡风险相关。
Am J Transl Res. 2023 Jun 15;15(6):4118-4128. eCollection 2023.
7
Coronary artery disease burden relation with the presentation of acute cardiac events and ventricular fibrillation.冠状动脉疾病负担与急性心脏事件和心室颤动的发生有关。
Catheter Cardiovasc Interv. 2022 Feb;99(3):804-811. doi: 10.1002/ccd.29858. Epub 2021 Jul 8.
8
Myocardial infarction and ventricular fibrillation due to iatrogenic right coronary artery occlusion following tricuspid valve annuloplasty: a case report.三尖瓣环成形术后医源性右冠状动脉闭塞导致心肌梗死和心室颤动:一例报告
Eur Heart J Case Rep. 2020 Nov 15;4(6):1-4. doi: 10.1093/ehjcr/ytaa328. eCollection 2020 Dec.
9
Prognostic Significance of Complex Ventricular Arrhythmias Complicating ST-Segment Elevation Myocardial Infarction.ST段抬高型心肌梗死合并复杂室性心律失常的预后意义
Am J Cardiol. 2018 Apr 1;121(7):805-809. doi: 10.1016/j.amjcard.2017.12.036. Epub 2018 Jan 12.
10
Antiarrhythmic drugs-clinical use and clinical decision making: a consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) Working Group on Cardiovascular Pharmacology, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and International Society of Cardiovascular Pharmacotherapy (ISCP).抗心律失常药物——临床应用与临床决策:欧洲心律协会(EHRA)和欧洲心脏病学会(ESC)心血管药理学工作组的共识文件,得到心律学会(HRS)、亚太心律学会(APHRS)和国际心血管药物治疗学会(ISCP)认可。
Europace. 2018 May 1;20(5):731-732an. doi: 10.1093/europace/eux373.